Early HIV Treatment to Optimize Patient Health and HIV Prevention
Agency: Centers for Disease Control and Prevention - ERA
Assistance Listings
- 93.941 -- HIV Demonstration, Research, Public and Professional Education Projects
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
The purpose of this project is to evaluate the feasibility of initiating antiretroviral therapy (ART) in persons diagnosed with acute or early HIV infection. We propose a prospective study of innovative approaches for initiating ART in persons diagnosed with acute or early HIV infection within days of their diagnosis. The primary outcomes of interest will be time to viral suppression and the proportion of patients who remain virally suppressed 12 months after diagnosis. Additional outcomes may include retention in HIV care, patient satisfaction with clinical care, changes in HIV transmission risk...
behavior, an evaluation of laboratory markers of viral suppression, and other outcomes as determined by patient input and the study investigators.
Eligibility
Eligible applicants
Miscellaneous
- Other
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Government
- Public and Indian housing authorities
- Special district governments
- County governments
- Federally recognized Native American tribal governments
- State governments
- City or township governments
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Additional information
Additional Information on Eligibility
Applicant organizations that request funding above the ceiling amount of the award will not be forwarded to peer review or considered for funding.
Grantor contact information
Description
Paul Smutz
POS1@cdc.gov
Grants Policy
Documents
| File name | Description | Last updated |
|---|---|---|
| rfa-ps-16-006.pdf | Early HIV Treatment to Optimize Patient Health and HIV Prevention | Jan 25, 2016 07:40 PM UTC |
Link to additional information
Archived: March 20, 2016
Award
$14,850,000
Program Funding
3
Expected awards
$300,000
Award Minimum
$495,000
Award Maximum
Funding opportunity number:
RFA-PS-16-006
Cost sharing or matching requirement:
No
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
2
Posted date:
December 10, 2015
Archive date:
March 20, 2016
